BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8844056)

  • 1. Transgenic mouse model for the fragile X syndrome.
    Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
    Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
    Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
    Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
    Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.
    Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT
    Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term potentiation in the hippocampus of fragile X knockout mice.
    Godfraind JM; Reyniers E; De Boulle K; D'Hooge R; De Deyn PP; Bakker CE; Oostra BA; Kooy RF; Willems PJ
    Am J Med Genet; 1996 Aug; 64(2):246-51. PubMed ID: 8844057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse.
    Mineur YS; Sluyter F; de Wit S; Oostra BA; Crusio WE
    Hippocampus; 2002; 12(1):39-46. PubMed ID: 11918286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
    Frankland PW; Wang Y; Rosner B; Shimizu T; Balleine BW; Dykens EM; Ornitz EM; Silva AJ
    Mol Psychiatry; 2004 Apr; 9(4):417-25. PubMed ID: 14981523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fragile gene.
    Oostra BA; Willems PJ
    Bioessays; 1995 Nov; 17(11):941-7. PubMed ID: 8526888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fragile X syndrome: a model of gene-brain-behaviour relationships].
    Hagerman RJ; Hagerman PJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S51-7. PubMed ID: 12447820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered synaptic plasticity in a mouse model of fragile X mental retardation.
    Huber KM; Gallagher SM; Warren ST; Bear MF
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7746-50. PubMed ID: 12032354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X syndrome, the Fragile X related proteins, and animal models.
    Hoogeveen AT; Willemsen R; Oostra BA
    Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.
    Koekkoek SK; Yamaguchi K; Milojkovic BA; Dortland BR; Ruigrok TJ; Maex R; De Graaf W; Smit AE; VanderWerf F; Bakker CE; Willemsen R; Ikeda T; Kakizawa S; Onodera K; Nelson DL; Mientjes E; Joosten M; De Schutter E; Oostra BA; Ito M; De Zeeuw CI
    Neuron; 2005 Aug; 47(3):339-52. PubMed ID: 16055059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
    Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
    J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the performance of individuals with fragile X syndrome and Fmr1 knockout mice on Hebb-Williams mazes.
    MacLeod LS; Kogan CS; Collin CA; Berry-Kravis E; Messier C; Gandhi R
    Genes Brain Behav; 2010 Feb; 9(1):53-64. PubMed ID: 19796132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
    el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
    Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mossy fiber distributions in adult Fmr1 (FVB) knockout mice.
    Ivanco TL; Greenough WT
    Hippocampus; 2002; 12(1):47-54. PubMed ID: 11918288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
    Qin M; Kang J; Smith CB
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.
    Li J; Pelletier MR; Perez Velazquez JL; Carlen PL
    Mol Cell Neurosci; 2002 Feb; 19(2):138-51. PubMed ID: 11860268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fragile balance: FMR1 expression levels.
    Oostra BA; Willemsen R
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R249-57. PubMed ID: 12952862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.